UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Prehabilitation for Patients with Cancer Undergoing Radiation Therapy: a Scoping Review

Clinical oncology (Royal College of Radiologists (Great Britain)), 2024-04, Vol.36 (4), p.254-264

2024

Volltextzugriff (PDF)

Investigating the Needs and Concerns of Lesbian, Gay, Bisexual, Transgender, Queer, or Questioning Cancer Patients

Journal of homosexuality, 2024-02, p.1-29

2024

Volltextzugriff (PDF)

SP-0025 Biomarkers of radiation-induced side effects in head & neck radiotherapy

Radiotherapy and oncology, 2023-05, Vol.182, p.S7-S7

Marignol, L.

2023

Volltextzugriff (PDF)

MGMT testing allows for personalised therapy in the temozolomide era

Tumor biology, 2016, Vol.37 (1), p.87-96

2016

Volltextzugriff (PDF)

SP-0187 CRISPR-Cas combination therapy: What's in it for radiotherapy?

Radiotherapy and oncology, 2022-05, Vol.170, p.S157-S157

Marignol, L.

2022

Volltextzugriff (PDF)

Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells

Scientific reports, 2016-10, Vol.6 (1), p.34796-34796, Article 34796

2016

Volltextzugriff (PDF)

EP-2042: Meta-analysis: can amifostine reduce chemoradiotherapy and radiotherapy toxicity in advanced NSCLC?

Radiotherapy and oncology, 2016-04, Vol.119, p.S964-S964

2016

Volltextzugriff (PDF)

Influence of inter-observer delineation variability on radiomic features of the parotid gland

Physica medica, 2021-02, Vol.82 (6-7), p.240-248

2021

Volltextzugriff (PDF)

A joint physics and radiobiology DREAM team vision – Towards better response prediction models to advance radiotherapy

Radiotherapy and oncology, 2024-07, Vol.196, p.110277-110277, Article 110277

2024

Volltextzugriff (PDF)

Hypoxia in prostate cancer: A powerful shield against tumour destruction?

Cancer treatment reviews, 2008-06, Vol.34 (4), p.313-327

2008

Volltextzugriff (PDF)

SP-062: Molecular radiation response of breast cancer: advances and clinical potential

Radiotherapy and oncology, 2019-12, Vol.141, p.S27-S27

Marignol, L.

2019

Volltextzugriff (PDF)

SP-036: Radiobiology of particles therapy: principles and latest advances

Radiotherapy and oncology, 2019-12, Vol.141, p.S15-S15

Marignol, L.

2019

Volltextzugriff (PDF)

Geometric and Dosimetric Evaluation of a Commercially Available Auto-segmentation Tool for Gross Tumour Volume Delineation in Locally Advanced Non-small Cell Lung Cancer: a Feasibility Study

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-03, Vol.33 (3), p.155-162

2021

Volltextzugriff (PDF)

PO-2219 Radiosensitivity Index as potential marker of biological sex differences to radiation response

Radiotherapy and oncology, 2023-05, Vol.182, p.S1996-S1996

2023

Volltextzugriff (PDF)

SP-0007: Gene editing: How this technique can be used to study radiation responses?

Radiotherapy and oncology, 2017-05, Vol.123, p.S1-S1

Marignol, L.

2017

Volltextzugriff (PDF)

Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance

Scientific reports, 2019-11, Vol.9 (1), p.17325-12, Article 17325

2019

Volltextzugriff (PDF)

PO-1061: Radiosensitisation properties of PI3K/AKT inhibitor GDC-0941 in prostate cancer cells

Radiotherapy and oncology, 2015-04, Vol.115, p.S572-S572

2015

Volltextzugriff (PDF)

PO-0982: Therapeutic potential of the YB-1/Notch-3 interaction in prostate cancer

Radiotherapy and oncology, 2016-04, Vol.119, p.S477-S477

2016

Volltextzugriff (PDF)

OC-0587: An assessment of compassion fatigue levels among radiation therapists working in Ireland, using the proQOL-v5

Radiotherapy and oncology, 2014, Vol.111, p.S231-S231

2014

Volltextzugriff (PDF)

The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers

Cancer biology & therapy, 2009-01, Vol.8 (2), p.118-124

2009

Volltextzugriff (PDF)

EP-1237: Identification of MiRNAs associated with radioresistance in a prostate cancer model

Radiotherapy and oncology, 2015-04, Vol.115, p.S670-S670

2015

Volltextzugriff (PDF)

Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells

Tumor biology, 2015-08, Vol.36 (8), p.6019-6028

2015

Volltextzugriff (PDF)

Radiotherapy scheduling using prime numbers

Journal of radiotherapy in practice, 2014-09, Vol.13 (3), p.317-321

2014

Volltextzugriff (PDF)

PO-1845: Time trend analysis of target volume autocontouring in locally advanced NSCLC over the course of RT

Radiotherapy and oncology, 2020-11, Vol.152, p.S1027-S1028

2020

Volltextzugriff (PDF)

PO-1054 Cancer community perceptions and knowledge of Radiation Therapy as a cancer treatment

Radiotherapy and oncology, 2022-05, Vol.170, p.S889-S890

2022

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(43)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Humans
(12)
Oncology
(11)
Hematology, Oncology And Palliative Medicine
(8)
Male
(7)
Prostate Cancer
(6)
Radiation
(6)
Cancer
(5)
Hypoxia
(5)
Cell Line, Tumor
(4)
Prostatic Neoplasms - Pathology
(4)
Prostatic Neoplasms - Radiotherapy
(4)
Proteins
(4)
Urology
(4)
Aged
(3)
Binding
(3)
Biology
(3)
Bioscience
(3)
Calcium
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prehabilitation for Patients with Cancer Undergoing Radiation Therapy: a Scoping Review

Investigating the Needs and Concerns of Lesbian, Gay, Bisexual, Transgender, Queer, or Questioning Cancer Patients

SP-0025 Biomarkers of radiation-induced side effects in head & neck radiotherapy

MGMT testing allows for personalised therapy in the temozolomide era

SP-0187 CRISPR-Cas combination therapy: What's in it for radiotherapy?

Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells

EP-2042: Meta-analysis: can amifostine reduce chemoradiotherapy and radiotherapy toxicity in advanced NSCLC?

Influence of inter-observer delineation variability on radiomic features of the parotid gland

A joint physics and radiobiology DREAM team vision – Towards better response prediction models to advance radiotherapy

Hypoxia in prostate cancer: A powerful shield against tumour destruction?

SP-062: Molecular radiation response of breast cancer: advances and clinical potential

SP-036: Radiobiology of particles therapy: principles and latest advances

Geometric and Dosimetric Evaluation of a Commercially Available Auto-segmentation Tool for Gross Tumour Volume Delineation in Locally Advanced Non-small Cell Lung Cancer: a Feasibility Study

PO-2219 Radiosensitivity Index as potential marker of biological sex differences to radiation response

SP-0007: Gene editing: How this technique can be used to study radiation responses?

Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance

PO-1061: Radiosensitisation properties of PI3K/AKT inhibitor GDC-0941 in prostate cancer cells

PO-0982: Therapeutic potential of the YB-1/Notch-3 interaction in prostate cancer

OC-0587: An assessment of compassion fatigue levels among radiation therapists working in Ireland, using the proQOL-v5

The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers

EP-1237: Identification of MiRNAs associated with radioresistance in a prostate cancer model

Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells

Radiotherapy scheduling using prime numbers

PO-1845: Time trend analysis of target volume autocontouring in locally advanced NSCLC over the course of RT

PO-1054 Cancer community perceptions and knowledge of Radiation Therapy as a cancer treatment

Suchergebnisse filtern